Skip to main content

Xiao-Fan Wang

Donald and Elizabeth Cooke Distinguished Professor of Cancer Research, in the School of Medicine
Pharmacology & Cancer Biology
Duke Box 3813, Durham, NC 27710
C218 Lev Sci Res Ctr, Durham, NC 27708

Overview


The current research in the Wang laboratory mainly focuses on the elucidation of molecular nature and signaling mechanisms associated with the initiation of cellular senescence. In addition, we continue to study changes in tumor microenvironment that promotes tumor progression and metastasis, particularly how tumor cells interact with the immune system. Ultimately, we hope that our studies in these areas to lead to the development of novel therapeutics for the treatment of various types of human cancer.

Current Appointments & Affiliations


Donald and Elizabeth Cooke Distinguished Professor of Cancer Research, in the School of Medicine · 2009 - Present Pharmacology & Cancer Biology, Basic Science Departments
Professor of Pharmacology and Cancer Biology · 2003 - Present Pharmacology & Cancer Biology, Basic Science Departments
Professor of Cell Biology · 2022 - Present Cell Biology, Basic Science Departments
Member of the Duke Cancer Institute · 1992 - Present Duke Cancer Institute, Institutes and Centers

In the News


Published March 7, 2025
Shift Toward Less Invasive Lung Surgeries

View All News

Recent Publications


WSTF nuclear autophagy regulates chronic but not acute inflammation.

Journal Article Nature · August 2025 Acute inflammation is an essential response that our bodies use to combat infections1. However, in the absence of infections, chronic inflammation can have a pivotal role in the onset and progression of chronic diseases, such as arthritis, cancer, autoimmu ... Full text Open Access Link to item Cite

Aberrant cytoplasmic expression of UHRF1 restrains the MHC-I-mediated anti-tumor immune response.

Journal Article Nat Commun · October 3, 2024 Immunotherapy successfully complements traditional cancer treatment. However, primary and acquired resistance might limit efficacy. Reduced antigen presentation by MHC-I has been identified as potential resistance factor. Here we show that the epigenetic r ... Full text Open Access Link to item Cite

Breaking NGF-TrkA immunosuppression in melanoma sensitizes immunotherapy for durable memory T cell protection.

Journal Article Nat Immunol · February 2024 Melanoma cells, deriving from neuroectodermal melanocytes, may exploit the nervous system's immune privilege for growth. Here we show that nerve growth factor (NGF) has both melanoma cell intrinsic and extrinsic immunosuppressive functions. Autocrine NGF e ... Full text Open Access Link to item Cite
View All Publications

Recent Grants


Pharmacological Sciences Training Program

Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2025 - 2030

Targeting Hepatocyte Senescence to Improve NAFLD

ResearchCo-Mentor · Awarded by National Institute of Diabetes and Digestive and Kidney Diseases · 2024 - 2029

The Duke Preparing Research scholars In bioMEdical sciences (PRIME): Cancer Research Program

ResearchPreceptor · Awarded by National Cancer Institute · 2023 - 2028

View All Grants

Education, Training & Certifications


University of California, Los Angeles · 1986 Ph.D.
Wuhan University (China) · 1982 B.S.

External Links


Wang Lab Website